May 2020 FDA Recall Clonidine Hydrochloride by Unichem Pharmaceuticals Usa Inc
D-1291-2020 - Failed Impurities/Degradation Specifications

This Class III drug recall was voluntarily initiated by Unichem Pharmaceuticals Usa Inc on May 26, 2020 for the product Clonidine Hydrochloride. The FDA reported the reason for recall as failed impurities/degradation specifications. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-1291-2020

Reason for Recall
Failed Impurities/Degradation Specifications: potential migration of benzophenone at very low level into the product from container.
Initiated
05-26-2020
Reported
06-17-2020
Quantity
190,992 bottles

Recall Profile & Regulatory Data

Class III - is a situation in which use of, or exposure to, a violative product is not likely to cause adverse health consequences.
UNICHEM PHARMACEUTICALS USA INC
Nationwide within the United States
Clonidine Hydrochloride Tablets, USP 0.1 mg 100-count bottles, Rx only, Manufactured by: Unichem Laboratories LTD. Pilerne Ind. Estate, Pilerne, Bardez, Goa 403 511, India Manufactured for : Unichem Pharmaceuticals (USA), Inc. East Brunswick, NJ 08816, NDC 29300-135-01

Batch or Lot Expiration Information

Lot# : GCLL19034, GCLL19035, GCLL19036, Exp. 4/30/2021; GCLL19044, Exp. 6/30/2021